Use of the prostate-specific antigen test among U.S. men: Findings from the 2005 National Health Interview Survey

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 3, 2008, Pages 636-644

  Ross, Louie E ^a,b   Berkowitz, Zahava ^a,c   Ekwueme, Donatus U ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b SHAW UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER;

AFRICAN AMERICANS; AGED; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; UNITED STATES;

EID: 41549136821     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2709     Document Type: Article

References (28)

1. U.S. Cancer Statistics Working Group. United States cancer statistics: 2004 incidence and mortality. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007. Available from: www.cdc.gov/cancer/npcr/npcrpdfs/ US_Cancer_Statistics_2004_Incidence_and_Mortality.pdf.
2. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007;110:2119-52.
3. Lieberman R. Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer. Am J Ther 2004;11:501-6.
4. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:915-6.
5. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007;57:90-104.
6. Finney Rutten LJ, Meissner HI, Breen N, Vernon SW, Rimer BK. Factors associated with men's use of prostate-specific antigen screening: evidence from Health Information National Trends Survey. Prev Med 2005;40:461-8.
7. Ross LE, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen (PSA) test use reported in the 2000 National Health Interview Survey. Prev Med 2004;38:732-44.
8. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003;289:1414-20.
9. Ross LE, Uhler RJ. Age, race, and repeated prostate-specific antigen (PSA) test use in the National Health Interview Survey. Ethn Dis 2006;16:244-7.
10. National Center for Health Statistics, National Health Interview Survey (machine readable data file and documentation). Hyattsville (MD): National Center for Health Statistics, Centers for Disease Control and Prevention; 2006.
11. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2002;97:1528-40.
12. National Center for Health Statistics (2006). National Health Interview Survey 2005 (NHIS). Questionnaires, datasets, and related documentation 1997-2007. Available at: http://www.cdc.gov/nchs/about/major/nhis/ quest_data_related_1997_forward.htm.
13. National Center for Health Statistics. National Health Interview Survey (NHIS). Public use data release NHIS survey description, Hyattsville (MD): Centers for Disease Control and Prevention, 1-112. 2005. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2005.
14. Shah BV, Barnwell BG, Bieler GS. SUDAAN. Research Triangle Park (NC): Research Triangle Institute; 2004.
15. Graubard BI, Korn EL Predictive margins with survey data. Biometrics 1999;55:652-9.
16. Cooper C, Merritt TL, Ross LE, John LV, Jorgensen CM. To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test. Prev Med 2004;38:182-91.
17. Stroud L, Ross LE, Rose SW. Formative evaluation of the prostate cancer screening practices of African-American physicians. J Natl Med Assoc 2006;98:1637-43.
18. Carter F, Graham E, Gonzalez E, Roetzheim R. Prostate cancer screening in primary care. South Med J 1999;92:300-4.
19. Weinrich SP, Boyd MD, Weinrich M, Greene F, Reynolds WA, Metlin C. Increasing prostate cancer screening in African American men with peer-educator and client-navigator interventions. J Cancer Educ 1998;13:213-9.
20. Weinrich SP, Boyd MD, Bradford D, Mossa M, Weinrich M. Recruitment of African Americans into prostate cancer screening. Cancer Pract 1998;6:23-30.
21. Weinrich SP, Holdford D, Boyd MD, et al. Prostate cancer education in African American churches. Public Health Nurs 1998;15:188-95.
22. Weinrich SP, Greiner E, Reis-Starr C, Yoon S, Weinrich M. Predictors of participation in prostate cancer screening at worksites. J Community Health Nurs 1998;15:113-29.
23. Etzioni R, Berry KM, Legler JM, Shaw P. Prostate-specific antigen testing in Black and White men: an analysis of Medicare claims from 1991-1998. Urology 2002;59:251-55.
24. Ekwueme DU, Stroud LA, Yanjing C. Cost analysis of testing for, diagnosing, and staging prostate cancer based on a systematic review of published studies. Prev Chronic Dis. 2007;4. Available from: http://www.cdc.gov/pcd/issues/2007/oct/06_0051.htm.
25. Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC. Cost analysis of the national breast and cervical cancer early detection program-selected states. Cancer 2008;112:626-35.
26. Jordan TR, Price JH, King KA, Masyk T, Bedell AW. The validity of male patients' self-reports regarding prostate cancer screening. Prev Med 1999;28:297-303.
27. Volk RJ, Cass AR. The accuracy of primary care patients' self-reports of prostate-specific antigen testing. Am J Prev Med 2002;22:56-8.
28. Paskett ED, Tatum CM, Mack DW, Hoen H, Case LD, Valez R. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev 1996;5:721-6.